Literature DB >> 33552511

Natural killer cells in inflammatory autoimmune diseases.

Yuyan Yang1,2, Jessica Day2,3,4, Fernando Souza-Fonseca Guimaraes5, Ian P Wicks2,3,4, Cynthia Louis2,3.   

Abstract

Natural killer (NK) cells are a specialised population of innate lymphoid cells (ILCs) that help control local immune responses. Through natural cytotoxicity, production of cytokines and chemokines, and migratory capacity, NK cells play a vital immunoregulatory role in the initiation and chronicity of inflammatory and autoimmune responses. Our understanding of their functional differences and contributions in disease settings is evolving owing to new genetic and functional murine proof-of-concept studies. Here, we summarise current understanding of NK cells in several classic autoimmune disorders, particularly in rheumatoid arthritis (RA), multiple sclerosis (MS), systemic lupus erythematosus (SLE) and type 1 diabetes mellitus (T1DM), but also less understood diseases such as idiopathic inflammatory myopathies (IIMs). A better understanding of how NK cells contribute to these autoimmune disorders may pave the way for NK cell-targeted therapeutics.
© 2021 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc.

Entities:  

Keywords:  autoimmune disease; idiopathic inflammatory myopathies; multiple sclerosis; natural killer cells; rheumatoid arthritis; systemic lupus erythematosus; type 1 diabetes mellitus

Year:  2021        PMID: 33552511      PMCID: PMC7850912          DOI: 10.1002/cti2.1250

Source DB:  PubMed          Journal:  Clin Transl Immunology        ISSN: 2050-0068


  184 in total

1.  Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation.

Authors:  Andrea De Maria; Federica Bozzano; Claudia Cantoni; Lorenzo Moretta
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

2.  Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity.

Authors:  Laurent Gauthier; Ariane Morel; Nadia Anceriz; Benjamin Rossi; Audrey Blanchard-Alvarez; Gwendoline Grondin; Sylvia Trichard; Cédric Cesari; Melody Sapet; Frédéric Bosco; Hélène Rispaud-Blanc; Franceline Guillot; Stéphanie Cornen; Alain Roussel; Béatrice Amigues; Guillaume Habif; Flavien Caraguel; Sandrine Arrufat; Romain Remark; François Romagné; Yannis Morel; Emilie Narni-Mancinelli; Eric Vivier
Journal:  Cell       Date:  2019-05-30       Impact factor: 41.582

3.  Dysregulated NK cell PLCγ2 signaling and activity in juvenile dermatomyositis.

Authors:  Allison A Throm; Joshua B Alinger; Jeanette T Pingel; Allyssa L Daugherty; Lauren M Pachman; Anthony R French
Journal:  JCI Insight       Date:  2018-11-15

4.  IL-23 suppresses innate immune response independently of IL-17A during carcinogenesis and metastasis.

Authors:  Michele W L Teng; Daniel M Andrews; Nicole McLaughlin; Bianca von Scheidt; Shin Foong Ngiow; Andreas Möller; Geoffrey R Hill; Yoichiro Iwakura; Martin Oft; Mark J Smyth
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

5.  NK cells dysfunction in systemic lupus erythematosus: relation to disease activity.

Authors:  Ana Henriques; Luís Teixeira; Luís Inês; Tiago Carvalheiro; Ana Gonçalves; António Martinho; Maria Luísa Pais; José António Pereira da Silva; Artur Paiva
Journal:  Clin Rheumatol       Date:  2013-02-02       Impact factor: 2.980

6.  Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients.

Authors:  Francesco Dotta; Stefano Censini; Astrid G S van Halteren; Lorella Marselli; Matilde Masini; Sabrina Dionisi; Franco Mosca; Ugo Boggi; Andrea Onetti Muda; Stefano Del Prato; John F Elliott; Antonello Covacci; Rino Rappuoli; Bart O Roep; Piero Marchetti
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-14       Impact factor: 11.205

7.  Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: role of CD94/NKG2A in control of cytokine secretion.

Authors:  Cristina Teixeira de Matos; Louise Berg; Jakob Michaëlsson; Li Felländer-Tsai; Klas Kärre; Kalle Söderström
Journal:  Immunology       Date:  2007-05-22       Impact factor: 7.397

8.  A subset of natural killer cells is greatly expanded within inflamed joints.

Authors:  Nicola Dalbeth; Margaret F C Callan
Journal:  Arthritis Rheum       Date:  2002-07

9.  Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis.

Authors:  J H Yen; B E Moore; T Nakajima; D Scholl; D J Schaid; C M Weyand; J J Goronzy
Journal:  J Exp Med       Date:  2001-05-21       Impact factor: 14.307

10.  Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells.

Authors:  B Zhang; T Yamamura; T Kondo; M Fujiwara; T Tabira
Journal:  J Exp Med       Date:  1997-11-17       Impact factor: 14.307

View more
  11 in total

1.  Revealing the Immune Heterogeneity between Systemic Lupus Erythematosus and Rheumatoid Arthritis Based on Multi-Omics Data Analysis.

Authors:  Yuntian Zhang; Tzong-Yi Lee
Journal:  Int J Mol Sci       Date:  2022-05-05       Impact factor: 6.208

Review 2.  Clinical translation of immunomodulatory therapeutics.

Authors:  Amanda Nash; Samira Aghlara-Fotovat; Andrea Hernandez; Christopher Scull; Omid Veiseh
Journal:  Adv Drug Deliv Rev       Date:  2021-07-27       Impact factor: 17.873

3.  Clinical and molecular parameters associated to pneumonitis development in non-small-cell lung cancer patients receiving chemoimmunotherapy from NADIM trial.

Authors:  Belén Sierra-Rodero; Alberto Cruz-Bermúdez; Ernest Nadal; Yago Garitaonaindía; Amelia Insa; Joaquín Mosquera; Joaquín Casal-Rubio; Manuel Dómine; Margarita Majem; Delvys Rodriguez-Abreu; Alex Martinez-Marti; Javier De Castro Carpeño; Manuel Cobo; Guillermo López Vivanco; Edel Del Barco; Reyes Bernabé Caro; Nuria Viñolas; Isidoro Barneto Aranda; Santiago Viteri; Bartomeu Massuti; Raquel Laza-Briviesca; Marta Casarrubios; Aránzazu García-Grande; Atocha Romero; Fernando Franco; Mariano Provencio
Journal:  J Immunother Cancer       Date:  2021-08       Impact factor: 13.751

4.  NK Cell Patterns in Idiopathic Inflammatory Myopathies with Pulmonary Affection.

Authors:  Marc Pawlitzki; Christopher Nelke; Leoni Rolfes; Rebecca Hasseli; Stylianos Tomaras; Eugen Feist; Anne Schänzer; Saskia Räuber; Liesa Regner; Corinna Preuße; Yves Allenbach; Olivier Benveniste; Heinz Wiendl; Werner Stenzel; Sven G Meuth; Tobias Ruck
Journal:  Cells       Date:  2021-09-27       Impact factor: 6.600

5.  Early-Life Adversity Leaves Its Imprint on the Oral Microbiome for More Than 20 Years and Is Associated with Long-Term Immune Changes.

Authors:  Eleftheria G Charalambous; Sophie B Mériaux; Pauline Guebels; Claude P Muller; Fleur A D Leenen; Martha M C Elwenspoek; Ines Thiele; Johannes Hertel; Jonathan D Turner
Journal:  Int J Mol Sci       Date:  2021-11-24       Impact factor: 5.923

6.  Associations of lymphocyte subpopulations with clinical phenotypes and long-term outcomes in juvenile-onset systemic lupus erythematosus.

Authors:  Butsabong Lerkvaleekul; Nopporn Apiwattanakul; Kanchana Tangnararatchakit; Nisa Jirapattananon; Supanart Srisala; Soamarat Vilaiyuk
Journal:  PLoS One       Date:  2022-02-07       Impact factor: 3.240

7.  Induction of Heme Oxygenase-1 Modifies the Systemic Immunity and Reduces Atherosclerotic Lesion Development in ApoE Deficient Mice.

Authors:  Leyi Yao; Yali Hao; Guanmei Wen; Qingzhong Xiao; Penglong Wu; Jinheng Wang; Jinbao Liu
Journal:  Front Pharmacol       Date:  2022-02-24       Impact factor: 5.810

8.  Natural Killer Cells Infiltration in the Joints Exacerbates Collagen-Induced Arthritis.

Authors:  Lisheng Wu; Ran Wang; Yi Zhou; Di Zhao; Feilong Chen; Xianghui Wu; Xiaoguang Chen; Shixian Chen; Juan Li; Junqing Zhu
Journal:  Front Immunol       Date:  2022-03-30       Impact factor: 7.561

Review 9.  Natural Killer Cells in Multiple Sclerosis: Entering the Stage.

Authors:  Jarne Beliën; An Goris; Patrick Matthys
Journal:  Front Immunol       Date:  2022-04-06       Impact factor: 8.786

Review 10.  Implications of NKG2A in immunity and immune-mediated diseases.

Authors:  Xiaotong Wang; Huabao Xiong; Zhaochen Ning
Journal:  Front Immunol       Date:  2022-08-10       Impact factor: 8.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.